Use of elsiglutida to treat gastrointestinal mucositis, including diarrhea induced by chemotherapy

• 收藏
• 分享

专利权人:

HELSINN HEALTHCARE SA

发明人:

CECILIA MORESINO,RICCARDO SPEZIA,FABIO TRENTO,SELMA CALCAGNILE,SIMONA RONCORONI,RUBEN GIORGINO

申请号：

ARP150102872

公开号：

AR103119A1

申请日:

2015.09.09

申请国别(地区):

AR

年份:

2017

代理人:

摘要：

Use of elsiglutida to prevent or reduce the incidence of gastrointestinal damage caused by chemotherapeutic agents, including gastrointestinal mucositis and chemotherapy-induced diarrhea (CID).Uso de elsiglutida para prevenir o reducir la incidencia de daño gastrointestinal causado por agentes quimioterapéuticos, incluyendo mucositis gastrointestinal y diarrea inducida por quimioterapia (CID).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/